MedPath

Effect of hydroquinone 4% topical cream versus glucosamine 2% topical cream on treatment of melasma

Phase 3
Recruiting
Conditions
Melasma.
Chloasma
L81.1
Registration Number
IRCT20120215009014N399
Lead Sponsor
Hamedan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
24
Inclusion Criteria

Age of 18 to 65 years;
Existence of mild melasma symmetrically on both sides of the face;

Exclusion Criteria

Pregnancy;
Existence of other skin diseases;
History of skin laser-therapy;
Using sunscreen;
Allergy to hydroquinone or glucosamine

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
esion size. Timepoint: Before the intervention and 2, 4, 6 and 8 weeks after that. Method of measurement: By photography.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath